Abstract
Prepulse inhibition (PPI) is a measure of sensorimotor gating which is widely used in rodents to study information processing and attention dysfunction. PPI is commonly measured in rats and mice using automated equipment. Here, we present details of a PPI testing protocol extensively used in previous studies. The protocol includes a set pulse-alone startle level and prepulse–pulse combinations with varying interval and intensity. Variations of this protocol can be used depending on the experimental aim or equipment and software version.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gómez-Nieto R, Hormigo S, López DE (2020) Prepulse inhibition of the auditory startle reflex assessment as a hallmark of brainstem sensorimotor gating mechanisms. Brain Sci 10:639
Light GA, Braff DL (1999) Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep 1:31–40
van den Buuse M (2007) Pre-pulse inhibition. In: Fink G (ed) Encyclopedia of stress, 2nd edn. Academic Press, Oxford, pp 180–183
van den Buuse M (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36:246–270
Gogos A, van den Buuse M (2022) Sex differences in psychosis: focus on animal models. Curr Top Behav Neurosci (in press)
van den Buuse M, Garner B, Gogos A, Kusljic S (2005) Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 39:550–557
Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107–128
Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156:194–215
Geyer MA, McIlwain KL, Paylor R (2002) Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7:1039–1053
Van den Buuse M, Garner B, Koch M (2003) Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition. Curr Mol Med 3:459–471
Gray L, van den Buuse M, Scarr E, Dean B, Hannan AJ (2009) Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol 12:45–60
McOmish CE, Burrows E, Howard M, Scarr E, Kim D, Shin HS, Dean B, van den Buuse M, Hannan AJ (2008) Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol Psychiatry 13:661–672
Gururajan A, Hill RA, van den Buuse M (2015) Brain-derived neurotrophic factor heterozygous mutant rats show selective cognitive changes and vulnerability to chronic corticosterone treatment. Neuroscience 284:297–310
Jaehne EJ, Ameti D, Paiva T, van den Buuse M (2017) Investigating the role of serotonin in methamphetamine psychosis: unaltered behavioral effects of chronic methamphetamine in 5-HT1A knockout mice. Front Psych 8:61
Jaehne EJ, Chong EMS, Sbisa A, Gillespie B, Hill R, Gogos A, van den Buuse M (2021) TrkB agonist 7,8-dihydroxyflavone reverses an induced prepulse inhibition deficit selectively in maternal immune activation offspring: implications for schizophrenia. Behav Pharmacol 32:404–412
Jaehne EJ, Kent JN, Antolasic EJ, Wright BJ, Spiers JG, Creutzberg KC, De Rosa F, Riva MA, Sortwell CE, Collier TJ, van den Buuse M (2022) Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory. Transl Psychiatry 12:93
Manning EE, van den Buuse M (2013) BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci 7:92
Notaras MJ, Hill RA, Gogos JA, van den Buuse M (2017) BDNF Val66Met genotype interacts with a history of simulated stress exposure to regulate sensorimotor gating and startle reactivity. Schizophr Bull 43:665–672
van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL (2011) Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: implications for schizophrenia. Neuropharmacology 61:209–216
Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199:331–388
Abel K, Waikar M, Pedro B, Hemsley D, Geyer M (1998) Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls. J Psychopharmacol 12:330–337
Aasen I, Kolli L, Kumari V (2005) Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J Psychopharmacol 19:39–45
Naysmith LF, Williams SCR, Kumari V (2022) The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: methodological considerations for drug and imaging research. J Psychopharmacol 36:1234–1242
Wynn JK, Dawson ME, Schell AM, McGee M, Salveson D, Green MF (2004) Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol Psychiatry 55:518–523
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
van den Buuse, M., Jaehne, E.J. (2024). Testing Prepulse Inhibition of Acoustic Startle in Rodents. In: Dworkin, S. (eds) Neurobiology. Methods in Molecular Biology, vol 2746. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3585-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3585-8_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3584-1
Online ISBN: 978-1-0716-3585-8
eBook Packages: Springer Protocols